keyboard_arrow_up

Adamas Pharmaceuticals, Inc. - Product Pipeline Review - 2013

Reportstack has announced a new market research publication on Adamas Pharmaceuticals, Inc. - Product Pipeline Review - 2013 which provides data on the Adamas Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. 

This report is built using data and information sourced from proprietary databases, Adamas Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Adamas Pharmaceuticals, Inc. and industry-specific third party sources, put together by team of industry experts. 

Scope

- Adamas Pharmaceuticals, Inc. - Brief Adamas Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Adamas Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Adamas Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. 
- Recent updates of the Adamas Pharmaceuticals, Inc.’s pipeline in the last quarter. 
- Key discontinued and dormant projects. 
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Adamas Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline. 
- Assess the growth potential of Adamas Pharmaceuticals, Inc. in its therapy areas of focus. 
- Identify new drug targets and therapeutic classes in the Adamas Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. 
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. 
- Exploit collaboration and partnership opportunities with Adamas Pharmaceuticals, Inc.. 
- Avoid Intellectual Property Rights related issues. 
- Explore the dormant and discontinued projects of Adamas Pharmaceuticals, Inc. and identify potential opportunities in those areas.

To view the table of contents and know more details please visit Adamas Pharmaceuticals, Inc. - Product Pipeline Review - 2013.